Overview of 3D Printing Technology

Hussain S
{"title":"Overview of 3D Printing Technology","authors":"Hussain S","doi":"10.23880/beba-16000149","DOIUrl":null,"url":null,"abstract":"The pharmaceutical industry is advancing at an incredible rate. Novel drug formulations for targeted therapy have been developed all thanks to advances in modern sciences. Even so, the manufacturing sector of novel dosage forms is minimal, and the industry continues to rely on traditional drug delivery systems, particularly modified tablets. The use of 3D printing technologies in pharma companies has opened up new possibilities for printed products and device research and production. 3D Printing has slowly progressed from its original use as pre-surgical imaging templates and tooling molds to produce one-of-a-kind instruments, implants, tissue engineering scaffolds, testing platforms, and drug delivery systems. The most significant advantages of 3D printing technologies include the ability to produce small batches of drugs with custom dosages, forms, weights, and drug release profiles. The production of medicines in this manner could eventually contribute to the realization of the principle of personalized medicine. The biomedical industry and academia have also embraced 3D printing in recent years. It offers commercially available medical devices as well as a forum for cutting-edge studies in fields such as tissue and organ printing. This mini-review provides an overview of 3D printed technology in medicines.","PeriodicalId":8995,"journal":{"name":"Bioequivalence & Bioavailability International Journal","volume":"10 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioequivalence & Bioavailability International Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23880/beba-16000149","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

The pharmaceutical industry is advancing at an incredible rate. Novel drug formulations for targeted therapy have been developed all thanks to advances in modern sciences. Even so, the manufacturing sector of novel dosage forms is minimal, and the industry continues to rely on traditional drug delivery systems, particularly modified tablets. The use of 3D printing technologies in pharma companies has opened up new possibilities for printed products and device research and production. 3D Printing has slowly progressed from its original use as pre-surgical imaging templates and tooling molds to produce one-of-a-kind instruments, implants, tissue engineering scaffolds, testing platforms, and drug delivery systems. The most significant advantages of 3D printing technologies include the ability to produce small batches of drugs with custom dosages, forms, weights, and drug release profiles. The production of medicines in this manner could eventually contribute to the realization of the principle of personalized medicine. The biomedical industry and academia have also embraced 3D printing in recent years. It offers commercially available medical devices as well as a forum for cutting-edge studies in fields such as tissue and organ printing. This mini-review provides an overview of 3D printed technology in medicines.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
3D打印技术概述
制药行业正以惊人的速度发展。由于现代科学的进步,用于靶向治疗的新型药物配方已经开发出来。即便如此,新剂型的制造部门仍然很少,该行业继续依赖于传统的给药系统,特别是改性片剂。在制药公司中使用3D打印技术为打印产品和设备的研究和生产开辟了新的可能性。3D打印已经从最初的手术前成像模板和模具用途慢慢发展到生产独一无二的仪器、植入物、组织工程支架、测试平台和药物输送系统。3D打印技术最显著的优势包括能够生产具有定制剂量、形式、重量和药物释放概况的小批量药物。以这种方式生产药品最终可能有助于实现个性化医疗原则。近年来,生物医学行业和学术界也开始接受3D打印技术。它提供商用医疗设备,以及组织和器官打印等领域的前沿研究论坛。这篇迷你评论提供了药物3D打印技术的概述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A Mini Review on Current Challenges and Opportunities in the Management of Bovine Mastitis In Vitro Anticancer and Cytotoxic Activity of Ethanolic Extract of Phyllanthus reticulatus Poir. Against Hela Cell Line and Vero Cell Line Will the Organic Food Phenomenon Continue or Fade Away? Unveiling Revealing Nature's Bounty: A Comprehensive Exploration of Bioavailability in Natural Products An Anti-Inflammatory and Analgesic Drug Etoricoxib Investigated by Design of Experimentation (DOE) and in Vitro Characterization
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1